Your browser doesn't support javascript.
loading
Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli.
Davies, Timothy J; Stoesser, Nicole; Sheppard, Anna E; Abuoun, Manal; Fowler, Philip; Swann, Jeremy; Quan, T Phuong; Griffiths, David; Vaughan, Alison; Morgan, Marcus; Phan, Hang T T; Jeffery, Katie J; Andersson, Monique; Ellington, Matt J; Ekelund, Oskar; Woodford, Neil; Mathers, Amy J; Bonomo, Robert A; Crook, Derrick W; Peto, Tim E A; Anjum, Muna F; Walker, A Sarah.
Afiliación
  • Davies TJ; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom timothy.davies@ndm.ox.ac.uk.
  • Stoesser N; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Sheppard AE; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Abuoun M; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Fowler P; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Swann J; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Quan TP; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Griffiths D; Bacteriology, Animal and Plant Health Agency, Surrey, United Kingdom.
  • Vaughan A; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Morgan M; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Phan HTT; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Jeffery KJ; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Andersson M; National Institute for Health Research Health Protection Research Unit on Healthcare Associated Infections and Antimicrobial Resistance at the University of Oxford, Oxford, United Kingdom.
  • Ellington MJ; NIHR Biomedical Research Centre, Oxford, United Kingdom.
  • Ekelund O; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Woodford N; NIHR Biomedical Research Centre, Oxford, United Kingdom.
  • Mathers AJ; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Bonomo RA; NIHR Biomedical Research Centre, Oxford, United Kingdom.
  • Crook DW; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Peto TEA; Nuffield Department of Medicine, Oxford University, Oxford, United Kingdom.
  • Anjum MF; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
  • Walker AS; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Article en En | MEDLINE | ID: mdl-32205351
ABSTRACT
Resistance to amoxicillin-clavulanate, a widely used beta-lactam/beta-lactamase inhibitor combination antibiotic, is rising globally, and yet susceptibility testing remains challenging. To test whether whole-genome sequencing (WGS) could provide a more reliable assessment of susceptibility than traditional methods, we predicted resistance from WGS for 976 Escherichia coli bloodstream infection isolates from Oxfordshire, United Kingdom, comparing against phenotypes from the BD Phoenix (calibrated against EUCAST guidelines). A total of 339/976 (35%) isolates were amoxicillin-clavulanate resistant. Predictions based solely on beta-lactamase presence/absence performed poorly (sensitivity, 23% [78/339]) but improved when genetic features associated with penicillinase hyperproduction (e.g., promoter mutations and copy number estimates) were considered (sensitivity, 82% [277/339]; P < 0.0001). Most discrepancies occurred in isolates with MICs within ±1 doubling dilution of the breakpoint. We investigated two potential causes the phenotypic reference and the binary resistant/susceptible classification. We performed reference standard, replicated phenotyping in a random stratified subsample of 261/976 (27%) isolates using agar dilution, following both EUCAST and CLSI guidelines, which use different clavulanate concentrations. As well as disagreeing with each other, neither agar dilution phenotype aligned perfectly with genetic features. A random-effects model investigating associations between genetic features and MICs showed that some genetic features had small, variable and additive effects, resulting in variable resistance classification. Using model fixed-effects to predict MICs for the non-agar dilution isolates, predicted MICs were in essential agreement (±1 doubling dilution) with observed (BD Phoenix) MICs for 691/715 (97%) isolates. This suggests amoxicillin-clavulanate resistance in E. coli is quantitative, rather than qualitative, explaining the poorly reproducible binary (resistant/susceptible) phenotypes and suboptimal concordance between different phenotypic methods and with WGS-based predictions.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Combinación Amoxicilina-Clavulanato de Potasio / Escherichia coli Tipo de estudio: Prognostic_studies / Qualitative_research País/Región como asunto: Europa Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Combinación Amoxicilina-Clavulanato de Potasio / Escherichia coli Tipo de estudio: Prognostic_studies / Qualitative_research País/Región como asunto: Europa Idioma: En Revista: Antimicrob Agents Chemother Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido